| Kevin L Kriley, RPH | |
|
125 S Main St, Smith Center, KS 66967-2605 | |
| (785) 282-6843 | |
| (785) 282-6844 |
| Full Name | Kevin L Kriley |
|---|---|
| Gender | Male |
| Speciality | Pharmacy |
| Location | 125 S Main St, Smith Center, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508919515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11052 (Kansas) | Secondary |
| 183500000X | Pharmacist | 29239 (Texas) | Secondary |
| 333600000X | Pharmacy | 208877 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kevin L Kriley, RPH 125 S Main St, Smith Center, KS 66967-2605 Ph: (785) 282-6843 | Kevin L Kriley, RPH 125 S Main St, Smith Center, KS 66967-2605 Ph: (785) 282-6843 |
News Archive
Carnegie Mellon University scientists have employed biological molecules to create a microgel that could recover costly enzymes for repeated use in catalyzing commercially important reactions. The microgel could potentially recover any enzyme and theoretically save manufacturers considerable money.
Scientists at The Scripps Research Institute have discovered a new pathway in cells that promotes mitochondrial function during times of stress, a response that can guard against disease as we age.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
A new study carried out by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Max Planck Institute for Colloids and Interfaces (Germany), the Free University of Berlin (Germany), UC San Diego, and Shinshu University (Japan) has identified a novel molecule that prevents T-cells from orchestrating asthma brought on by allergens.
Despite heightened awareness about the undue influence that gifts from pharmaceutical companies can have on doctors' prescribing practices, and despite expanding institutional conflict-of-interest policies and state laws targeted at preventing such practices, companies continue to reward doctors for prescribing their drugs with gifts ranging from pens and paper, to free dinners and trips.
› Verified 5 days ago